GT Biopharma (GTBP) Shares Outstanding (Entity) (2009 - 2026)
GT Biopharma's Shares Outstanding (Entity) came in at 1.79 million for Q2 2026, up 27.0% from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Shares Outstanding (Entity) (2009 - 2026) Analysis & Trends
For FY2025, GT Biopharma's Shares Outstanding (Entity) was 220,530, up 146.8% from FY2024.
- Shares Outstanding (Entity) has increased in each of the last five years, with a five-year compound annual growth rate of 106.7% (FY2020 to FY2025).
- Going back by year, Shares Outstanding (Entity) was 89,373 in FY2024 (+61.8%), 55,240 in FY2023 (+26.6%), 43,626 in FY2022 (+2.1%) and 42,745 in FY2021 (+631.2%).
- The Q2 2026 figure represents the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2009.
- The year-over-year growth in Shares Outstanding (Entity) has ranged between 2.1% (Q4 2022) and 631.2% (Q4 2021) over the last five years.
- Business Quant data shows GTBP's Shares Outstanding (Entity) at 1.41 million (Q1 2026), 220,530 (Q4 2025) and 157,629 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 940.75 Mn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 540.90 Mn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 5.70 Bn |
| 10 | GT Biopharma | 6.65 Mn | -16.58 Mn | - | 1.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.79 Mn |
| Mar 31, 2026 | 1.41 Mn |
| Dec 31, 2025 | 220,530.00 |
| Sep 30, 2025 | 157,629.00 |
| Mar 31, 2025 | 101,456.00 |
| Dec 31, 2024 | 89,373.00 |
| Sep 30, 2024 | 89,373.00 |
| Jun 30, 2024 | 68,478.00 |
| Mar 31, 2024 | 55,225.00 |
| Dec 31, 2023 | 55,240.00 |
| Sep 30, 2023 | 55,220.00 |
| Jun 30, 2023 | 54,181.00 |
| Mar 31, 2023 | 49,172.00 |
| Dec 31, 2022 | 43,626.00 |
| Sep 30, 2022 | 43,339.00 |
| Jun 30, 2022 | 40,921.00 |
| Mar 31, 2022 | 43,123.00 |
| Dec 31, 2021 | 42,745.00 |
| Sep 30, 2021 | 40,674.00 |
| Jun 30, 2021 | 37,522.00 |
API Access
GT Biopharma Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();